ACCORD is a partnership between the University of Edinburgh and NHS Lothian, combining clinical research expertise. We offer streamlined access to expert guidance, regulatory support, and state-of-the-art research infrastructure. Supporting both academic and commercial researchers across the UK and beyond, our work is grounded in Scotland’s first joint Research Framework Agreement - ensuring excellence at every stage of your research journey.

For Researchers

Researchers discussing ideas

We can support your research

For the Public

Participants in discusson around a table

Get involved in research

For Industry

Researchers coming up with an idea around a table

Collaborate with us

Researchers and a large pencil

ACCORD Annual Review 2025

The ACCORD Annual Review 2025 showcases the breadth and impact of clinical research across NHS Lothian and the University of Edinburgh, highlighting outstanding local investigators, innovative trials, and the infrastructure investments shaping the future of research delivery in Scotland.

Research strategy

Strategic Plan 2022-2027

The R&D Strategic Plan outlines a bold five‑year vision to embed clinical research across all NHS services, strengthening workforce capacity, research governance, patient and public involvement, and collaborative partnerships - with the aim that every patient has the opportunity to participate in research.

Clinical Trial Pathway: Survey of Stakeholders 2025

Earlier in 2025, the University of Edinburgh’s Clinical Trials Oversight Group (CTOG) surveyed members of the clinical trials community. Responses highlighted responsive and skilled teams but identified some challenges around governance, finances, and administration. The survey also revealed a need for clearer orientation, better coordination between the University and NHS Lothian, and improved efficiency and staff support. As a CTOG stakeholder, ACCORD is now addressing the feedback we received.

We now have a refreshed ACCORD website, improving access to information and contacts and clarifying sponsorship roles in ACCORD. Other plans include:

  • Continue to develop training resources and opportunities
  • Improve financial guidance & training
  • Refine Sponsor processes and resources, including templates and guidance
  • Clarify risk assessment requirements, including the provision of FAQs
  • Provide text examples for completion of forms for research approvals
  • Reduce duplication of technical assurances for research e.g. information governance
  • Update our QA management system in line with the new clinical trials regulations

This article was published on